Laurel Geraghty, MD
Dermatology · Medford, ORNPI 1548526114
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $5,475 of the $6,355 with a category attached, or 86.1%. Galderma Laboratories, L.p. accounts for 86.3% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2021 at $5,482 and has fallen 97.0% since, to $166 in 2025.
Across 49 payments — averaging $129.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Galderma Laboratories, L.p.$5K
- AbbVie$465
- Lilly USA, LLC$141
- Johnson & Johnson$88
- Sanofi$64
- UCB, Inc.$50
- plus $66 from 3 others
What the payments were for
- Speaking & faculty fees$5,47586%
- Food & beverage$88014%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Galderma Laboratories, L.p. | 4 | $5,482 |
| AbbVie | 23 | $465 |
| Lilly USA, LLC | 8 | $141 |
| Johnson & Johnson | 5 | $88 |
| Sanofi | 3 | $64 |
| UCB, Inc. | 2 | $50 |
| Novartis | 2 | $39 |
| Incyte Corporation | 1 | $17 |
| Organon | 1 | $10 |
How this compares
$6,355 in reported general payments places this provider in the 75th percentile of 175 dermatology providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 11 | $41,097 |
| Clobetasol Propionate | 134 | $3,342 |
| Metronidazole | 53 | $2,467 |
| Fluorouracil | 41 | $2,199 |
| Tretinoin | 21 | $1,650 |
| Fluocinonide | 43 | $1,455 |
| Triamcinolone Acetonide | 145 | $1,198 |
| Ketoconazole | 67 | $1,180 |
| ValacyclovirValacyclovir Hcl | 46 | $960 |
| Imiquimod | 30 | $773 |
| Nystatin | 37 | $739 |
| Doxycycline Monohydrate | 25 | $699 |
| Doxycycline Hyclate | 23 | $628 |
| Hydroxychloroquine Sulfate | 15 | $576 |
| Mupirocin | 69 | $564 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Medford
- Thomas EvansMedford$4K
- Natasha ZacherMedford$4K
- Douglas NaversenMedford$4K
- Andrew BlauveltPortland$1.8M
- Benjamin EhstPortland$1.5M
- Jason HawkesPortland$1.5M
- Eric SimpsonPortland$1.4M
- Collin BlattnerThe Dalles$409K
- Alex Ortega LoayzaPortland$122K
- Omar QutubPortland$107K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.